Work

Tumoral immune-infiltrate (IF), PD-L1 expression and role of CD8/TIA-1 lymphocytes in localized osteosarcoma patients treated within protocol ISG-OS1

Year: 2017
Type: article
Abstract: // Emanuela Palmerini 1 , Claudio Agostinelli 2 , Piero Picci 1 , Stefano Pileri 3, 4 , Teresa Marafioti 5 , Pier-Luigi Lollini 6 , Katia Scotlandi 1 , Alessandra Longhi 1 , Maria Serena Benassi 1 and Stefano Ferrari 1 1 Chemotherapy Unit, IRCCS, Istituto Ortopedico Rizzoli, Bologna, Italy 2 Haematopathology Unit, Policlinico S. Orsola-Malpighi, Bologna, Italy 3 Haematopathology Unit, European Institute of Oncology, Milan, Italy 4 Bologna University School of Medicine, Bologna, Italy 5 University College London Cancer Institute, London, United Kingdom 6 Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy Correspondence to: Emanuela Palmerini, email: [email protected] Keywords: osteosarcoma; PD-1; PD-L1; CD8; tumor microenvironment Received: July 19, 2017 Accepted: November 15, 2017 Published: December 04, 2017 ABSTRACT Background: We hypothesized that immune-infiltrates were associated with superior survival, and examined a primary osteosarcoma tissue microarrays (TMAs) to test this hypothesis. Methods: 129 patients (pts) with localized osteosarcoma treated within protocol ISG-OS1 were included in the study. Clinical characteristics, expression of CD8, CD3, FOXP3, CD20, CD68/CD163 (tumor associated macrophage, TAM), Tia-1 (cytotoxic T cell), CD303 (plasmacytoid dendritic cells: pDC), Arginase-1 (myeloid derived suppressor cells: MDSC), PD-1 on immune-cells (IC), and PD-L1 on tumoral cells (TC) and IC were analysed and correlated with outcome. Results: Most of the cases presented tumor infiltrating lymphocytes (TILs) (CD3+ 90%; CD8+ 86%). Tia-1 was detected in 73% of the samples. PD-L1 expression was found in 14% patients in IC and 0% in TC; 22% showed PD-1 expression in IC. With a median follow-up of 8 years (range 1-13), the 5-year overall survival (5-year OS) was 74% (95% CI 64-85). Univariate analysis showed better 5-year OS for: a) pts with a good histologic response to neoadjuvant chemotherapy (p = 0.0001); b) pts with CD8/Tia1 tumoral infiltrates (p = 0.002); c) pts with normal alkaline phosphatas (sALP) (p = 0.04). After multivariate analysis, histologic response (p = 0.007) and CD8/Tia1 infiltration (p = 0.01) were independently correlated with survival. In the subset of pts with CD8+ infiltrate, worse (p 0.02) OS was observed for PD-L1(IC)+ cases. Conclusions: Our findings support the hypothesis that CD8/Tia1 infiltrate in tumor microenvironment at diagnosis confers superior survival for pts with localized osteosarcoma, while PD-L1 expression is associated with worse survival.
Source: Oncotarget
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: diamond
OpenAlex ID: W2774372124
FWCI: 3.101
Cites: 32
Cited by: 69
Related to: 10